These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 3263594
21. MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys. Miletich RS, Bankiewicz KS, Quarantelli M, Plunkett RJ, Frank J, Kopin IJ, Di Chiro G. Ann Neurol; 1994 Jun; 35(6):689-97. PubMed ID: 8210225 [Abstract] [Full Text] [Related]
22. The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Burns RS, LeWitt PA, Ebert MH, Pakkenberg H, Kopin IJ. N Engl J Med; 1985 May 30; 312(22):1418-21. PubMed ID: 2581135 [Abstract] [Full Text] [Related]
23. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study. Gnanalingham KK, Smith LA, Hunter AJ, Jenner P, Marsden CD. Synapse; 1993 Jun 30; 14(2):184-94. PubMed ID: 8332947 [Abstract] [Full Text] [Related]
24. Protective action of recombinant neurturin on dopaminergic neurons in substantia nigra in a rhesus monkey model of Parkinson's disease. Li H, He Z, Su T, Ma Y, Lu S, Dai C, Sun M. Neurol Res; 2003 Apr 30; 25(3):263-7. PubMed ID: 12739234 [Abstract] [Full Text] [Related]
25. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease. Jenner P, Marsden CD. J Neural Transm Suppl; 1986 Apr 30; 20():11-39. PubMed ID: 3091760 [Abstract] [Full Text] [Related]
26. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse. Ferraro TN, Golden GT, DeMattei M, Hare TA, Fariello RG. Neuropharmacology; 1986 Sep 30; 25(9):1071-4. PubMed ID: 2430229 [Abstract] [Full Text] [Related]
27. Sensitization of dopamine-stimulated adenylyl cyclase in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys and patients with idiopathic Parkinson's disease. Pifl C, Nanoff C, Schingnitz G, Schütz W, Hornykiewicz O. J Neurochem; 1992 Jun 30; 58(6):1997-2004. PubMed ID: 1349341 [Abstract] [Full Text] [Related]
28. [Experimental research on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian animal models in the rhesus monkey and C57 black mouse]. Chen S. Zhonghua Yi Xue Za Zhi; 1990 May 30; 70(5):252-4, 18. PubMed ID: 2168792 [Abstract] [Full Text] [Related]
29. Evidence for neuromelanin involvement in MPTP-induced neurotoxicity. D'Amato RJ, Alexander GM, Schwartzman RJ, Kitt CA, Price DL, Snyder SH. Nature; 1990 May 30; 327(6120):324-6. PubMed ID: 2884568 [Abstract] [Full Text] [Related]
30. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys. Rioux L, Frohna PA, Joyce JN, Schneider JS. Mov Disord; 1997 Mar 30; 12(2):148-58. PubMed ID: 9087972 [Abstract] [Full Text] [Related]
31. 6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys. Doudet DJ, Chan GL, Holden JE, McGeer EG, Aigner TA, Wyatt RJ, Ruth TJ. Synapse; 1998 Jul 30; 29(3):225-32. PubMed ID: 9635892 [Abstract] [Full Text] [Related]
32. Cerebral metabolism of parkinsonian primates 21 days after MPTP. Schwartzman RJ, Alexander GM, Ferraro TN, Grothusen JR, Stahl SM. Exp Neurol; 1988 Dec 30; 102(3):307-13. PubMed ID: 3264247 [Abstract] [Full Text] [Related]
33. Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP. Rose S, Nomoto M, Kelly E, Kilpatrick G, Jenner P, Marsden CD. Neurosci Lett; 1989 Jul 03; 101(3):305-10. PubMed ID: 2505199 [Abstract] [Full Text] [Related]
34. Changes in the local cerebral metabolic rate for glucose in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease. Schwartzman RJ, Alexander GM. Brain Res; 1985 Dec 09; 358(1-2):137-43. PubMed ID: 3878182 [Abstract] [Full Text] [Related]
35. Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys. Mochizuki H, Imai H, Endo K, Yokomizo K, Murata Y, Hattori N, Mizuno Y. Neurosci Lett; 1994 Feb 28; 168(1-2):251-3. PubMed ID: 8028787 [Abstract] [Full Text] [Related]
36. Increased susceptibility of G-protein coupled receptor 6 deficient mice to MPTP neurotoxicity. Oeckl P, Ferger B. Neuroscience; 2016 Nov 19; 337():218-223. PubMed ID: 27651149 [Abstract] [Full Text] [Related]
37. Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, but not sham-grafted, MPTP-treated parkinsonian monkeys. Elsworth JD, Brittan MS, Taylor JR, Sladek JR, al-Tikriti MS, Zea-Ponce Y, Innis RB, Redmond DE, Roth RH. Cell Transplant; 1996 Nov 19; 5(2):315-25. PubMed ID: 8689042 [Abstract] [Full Text] [Related]
38. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study. Hadjiconstantinou M, Mariani AP, Neff NH. Brain Res; 1989 Apr 10; 484(1-2):297-303. PubMed ID: 2565752 [Abstract] [Full Text] [Related]
39. Extrastriatal dopamine in symptomatic and asymptomatic rhesus monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Pifl C, Bertel O, Schingnitz G, Hornykiewicz O. Neurochem Int; 1990 Apr 10; 17(2):263-70. PubMed ID: 20504626 [Abstract] [Full Text] [Related]
40. Synthesis and toxicity toward nigrostriatal dopamine neurons of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogues. Fries DS, de Vries J, Hazelhoff B, Horn AS. J Med Chem; 1986 Mar 10; 29(3):424-7. PubMed ID: 3485197 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]